Large infarcts develop in pinealectomized rats subjected to middle cerebral artery occlusion, which was at tributed to loss of antioxidant action of melatonin. However, melatonin also has vascular actions, and pine alec to my may induce hypertension. The authors investigated (I) whether he modynamic factors contribute to infarct development in pine alectomized rats, (2) whether melatonin administration can re verse the unfavorable effect of pinealectomy on infarct forma tion, and (3) whether melatonin can reduce the infarct volume in nonpinealectomized rats subjected to focal transient isch emia (2 hours middle cerebral artery occlusion, 22 hours reper fusion). Rats were pinealectomized 3 months before ischemia to eliminate any possible action of pinealectomy-induced hy pertension on stroke. Blood pressure and regional CBF values
Lack of a serious tOXICIty of melatonin, a powerful antioxidant, has recently evoked hopes that it might be a promising drug for treatment of various diseases thought to be caused by oxidative damage (Reiter et aI., 1997b) . Melatonin has also been proposed as a neuroprotective agent as it readily penetrates the blood-brain barrier and diffuses into neurons and glia equally well (Reiter et aI., 1997a) . Supporting the above view, melatonin adminis tration has been demonstrated to decrease kainic acid induced excitotoxicity and traumatic injury in the brain (Giusti et aI., 1996 (Giusti et aI., , 1997 Mesenge et aI., 1998) . More over, larger lesions developed when pinealectomized rats were subjected to intracerebral kainic acid injections or to middle cerebral artery (MCA) occlusion (Mane v et aI., 1996) . Although the latter findings suggest a protective during ischemia and reperfusion were not significantly differ ent between pinealectomized and sham-operated rats, suggest ing that pinealectomy-induced increase in infarct was not re lated to hemodynamic factors. The infarct volume resumed to the level of sham-operated rats on melatonin administration. Injection of melatonin (4 mg/kg) before both ischemia and reperfusion reduced infarct volume by 40% and significantly improved neurologic deficit scores in pinealectomized as well as sham-operated rats subjected to middle cerebral artery oc clusion. These data suggest that physiologic melatonin release as well as exogenously given melatonin has a neuroprotective action in focal cerebral ischemia. Key Words: Melatonin Pine alec to my-Cerebral ischemia-N europrotection Cerebral blood flow-Antioxidants.
action by physiologic levels of melatonin against isch emic brain damage and excitotoxicity, increased vulner ability of the brain might also have been caused by other changes that pinealectomy induced (Moller et aI., 1996) .
Pinealectomy leads to an increase in systemic arterial blood pressure (Karppanen et aI., 1975; Zanoboni et aI., 1978; Vaughan et aI., 1979) in addition to a drastic re duction in circulating levels of melatonin (Ozaki and Lynch 1976; Lewy et aI., 1980; Bubenik and Brown, 1997) . Cerebral vessels express melatonin receptors (Viswanathan et aI., 1990 (Viswanathan et aI., , 1997 , and in vitro, melatonin has been shown to induce concentration-dependent va soconstriction or dilation (Geary et aI., 1997; Mahle et aI., 1997) . Melatonin administration to 14-day-old rats has been found to cause a reduction in cerebral blood flow (Capsoni et aI., 1995) . Therefore, determining the arterial blood pressure and cerebral blood flow appears to be warranted to test any possible contribution of he modynamic factors to the unfavorable effect of pinealec tomy on brain damage.
In this study, we monitored the arterial pressure and regional cerebral blood flow (rCBF) in pinealectomized rats subjected to MeA occlusion. We also administered varying doses of melatonin before induction of ischemia or reperfusion to determine whether the unfavorable ac tion of pinealectomy on cerebral ischemia could be re versed by melatonin and to find the optimum dose and timing of melatonin administration. Our data suggest that the large infarcts in pinealectomized rats are caused by changes in brain parenchyma induced by melatonin de ficiency but not by hemodynamic factors. The infarct volume resumed to the level of sham-operated rats on administration of melatonin. A combined administration of melatonin before both ischemia and reperfusion led to a significant decrease in infarct in pinealectomized as well as sham-operated rats subjected to MeA occlusion, strongly supporting the role of melatonin as a neuropro tective agent.
METHODS

Experimental groups
Wi star rats weighing 230 to 270 g were housed under diurnal lighting conditions (12 hours darkness and 12 hours light) and fasted overnight but allowed free access to water before the experiment. Animal housing, care, and application of experi mental procedures were all done in accordance with institu tional guidelines. Rats were anesthetized with ketamine hydro chloride (75 mg/kg) and xylazine (8 mg/kg). Body temperature was monitored by a rectal probe and maintained at 36.5° to 37.5°C by a homeothermic blanket control unit.. The tail artery was cannulated for continuous arterial blood pressure monitor ing, for obtaining blood samples to determine pH, Pco2, Po2, and hematocrit, for melatonin or vehicle administration, and for heparinization (30 U just before ischemia). Twenty-five pine alectomized and 14 sham-operated rats were subjected to 2 hours of proximal MCA occlusion and 22 hours of reperfusion. Pinealectomized rats were studied in five groups: 5 rats were injected with vehicle solution, melatonin was given before isch emia (4 mg/kg, 4 rats) or reperfusion (4 or 8 mg/kg, 5 and 4 rats, respectively), or before both ischemia and reperfusion (4 + 4 mg/kg, 7 rats). Eight sham-operated rats received vehicle injection, and melatonin was given to 6 sham-operated rats both before ischemia (4 mg/kg) and reperfusion (4 mg/kg).
Melatonin (Sigma Chemical Co., St. Louis, MO, U.S.A.) was dissolved in ethanol and further diluted in saline to give a final ethanol concentration of 5%.
Pinealectomy
Pinealectomy was performed as described by Kuszak and Rodin (1977) . Briefly, anesthetized rats were placed in a ste reotaxic frame and a longitudinal midline incision was made and extended to the occipital ridge. The sagittal and lambdoid sutures were then exposed by scraping the periosteum. A rect angular piece of the calvarium was opened and the superior sagittal vein (SSV), transverse sinuses, and confluens sinuum were exposed. Great care was exercised in drilling and remov ing the piece of bone so as not to cause hemorrhage from the underlying sinuses. The dura was then cut, and the SSV was double-ligated with 6-0 silk surgical threads, placed under the SSV with a curved atraumatic needle, and resected. The pineal gland was exposed beneath the confluens sinuum by reflecting the caudal portion of the ligated SSV posteriorly and was re moved with fine forceps. The procedure was completed by returning the reflected SSV to its original position, reapposing J Cereb Blood Flow Metab. Vol. 19, No.5, 1999 the skin, and closing the incision. The entire procedure was completed within 15 minutes.
MeA occlusion
Proximal occlusion of the right MCA was performed by a ny Ion filament as described before (Longa et aI., 1989; Memezewa et aI., 1992) . After a midline incision, the right common and external carotid arteries were ligated with a 5-0 silk suture. A 4-0 nylon filament was inserted into the common carotid artery through a small incision 1 to 2 mm proximal to the bifurcation. The filament was prepared by blunting the tip near a flame and its distal 5 mm was coated with cyanoacrylate glue. Middle cerebral artery occlusion was accomplished by further advancing the filament in the internal carotid artery until a faint resistance was felt.
A small burr hole was made over the cortex (6 mm lateral and 2 mm posterior to bregma), and a flexible probe (PF-318 of PeriFlux PF 2B, Perimed, Jarfalla, Sweden) was placed over the dura, away from large pial vessels, to monitor the rCBF by laser-Doppler flowmetry. After obtaining a stable lO-minute period of preis chemic rCBF, the MCA was occluded and the rCBF was continuously monitored during ischemia (2 hours) and for the first 20 minutes of reperfusion.
Reperfusion was accomplished by pulling the filament back. Animals that were not successfully reperfused (n = 2, 4.5% of the rats studied) or had subarachnoid hemorrhage (n = 4, 9%) were excluded from the study.
Evaluation of ischemic area by 2,3,5-triphenyl tetrazolium chloride staining
The ischemic area was evaluated by 2,3,5-triphenyl tetrazo lium chloride staining (Bederson et. aI., 1986b) . Briefly, rats were killed by decapitation after 2 hours of ischemia and 22 hours of reperfusion. The brains were quickly removed and placed in ice-cold saline for 5 minutes and then cut into 2-mm coronal slices. Sections were incubated in 2,3,5-triphenyl tet razolium chloride containing saline solution (2%; Sigma) for 20 minutes and in 10% formalin overnight. The infarction area, outlined in white, was measured by image analysis software (NIH Image 1.59) on the posterior surface of each section, and infarction volume was calculated by summing the infarct vol umes of sequential 2-mm thick sections.
Neurologic evaluation
Twenty-two hours after recirculation, neurologic deficits were assessed by an observer naive to the identity of treatment and scored as described previously (Bederson et aI., 1986a; Huang et aI., 1994) with a minor modification as follows: 0, no observable neurologic deficit (normal); 1, failure to extend left forepaw on lifting the whole body by the tail (mild); 2, circling to the contralateral side (moderate); and 3, leaning to the con tralateral side at rest or no spontaneous motor activity (severe).
Statistics
Mean values of arterial blood gases, pH, blood pressure, rCBF, infarct volume, and neurologic deficit scores were com pared by analysis of variance and Fisher's protected least significant difference test was used for post-hoc analysis. Prob ability values smaller than 0.05 were considered to be signifi cant. Mean values in the text are given with their standard deviations.
RESULTS
Arterial blood gases, pH, and pressure were not sig nificantly different between the experimental groups, al-MELATONIN ATTENUATES FOCAL ISCHEMIC DAMAGE 5/3 though pinealectomized (Px) rats had slightly lower blood pressure values than sham-operated (non-Px) rats. Regional CBF values during MCA occlusion and reper fusion were also not significantly different between the groups (Table 1) .
Infarct volume
Pinealectomy caused a significant increase in infarct volume. Two-hour MCA occlusion followed by 22 hours of reperfusion led to 232 ± 74 and 306 ± 16 mm 3 infarcts in non-Px and Px rats, respectively (Fig. lA) . Adminis tration of 4 mg/kg of melatonin to Px rats just before the induction of ischemia or reperfusion decreased the in farct volume to values comparable to those of the non-Px group. The infarct volumes were 227 ± 66 and 188 ± 58 mm 3 for groups given melatonin before ischemia or reperfusion, respectively. Although these values were significantly smaller than the mean infarct volume of the vehicle-treated Px group, they were not significantly dif ferent from that of the non-Px group (232 ± 74 mm 3 ). Increasing the dose administered before reperfusion to 8 mg/kg also did not achieve a significantly reduced infarct volume (2 12 ± 18 mm 3 ). Combined administration of 4 mg/kg melatonin to Px rats before both ischemia and reperfusion, however, led to a further reduction in the infarct volume to 140 ± 58 mm 3 (60% of the infarct in the non-Px group). A similar protection with combined melatonin administration was also obtained in the non Px group subjected to MCA occlusion (151 ± 66 mm 3 ).
Neurologic evaluation
Mean scores of all groups indicating the neurologic disability of rats 22 hours after reperfusion paralleled the changes in infarct volume (Fig. IB) . Pinealectomized rats had significantly higher disability scores than those of non-Px rats. Melatonin (4 mg/kg) administration be fore reperfusion significantly reduced the disability of Px All values are mean ± SD. There were no statistically significant differences between groups by ANOV A.
* Melatonin was administered just before ischemia (I) or reperfusion (R) at a dose of 4 or 8 mg/kg. animals to the level of non-Px rats. Unlike the infarct volumes, neurologic deficit scores of groups in which 4 mg/kg melatonin was given before ischemia or 8 mg/kg melatonin was given before reperfusion were not signifi cantly lower than scores of the Px group, possibly be cause of insufficient number of animals in these groups to overcome the variability in neurologic disability. The combined administration of melatonin before both isch emia and reperfusion led to a further reduction in neu rologic dysfunction, which was significantly less than that of the non-Px group. Nonpinealectomized rats sub jected to 2 hours of MCA occlusion and 22 hours of reperfusion and given combined melatonin treatment also had significantly lower disability scores than ve hicle-treated non-Px rats.
DISCUSSION
Manev's group was the first to report that pinealecto mized rats were more vulnerable to kainate-induced ex citotoxicity and photo thrombotic brain injury (Manev et aI., 1996) . They also demonstrated that larger infarcts developed in pinealectomized rats subjected to 1 hour of MCA occlusion (Manev et aI., 1996) . However, the ar terial blood pressure and cerebral blood flow were not monitored in these pioneering studies. Although the an tioxidant property of melatonin might account for its neuroprotective effect, monitoring cerebral blood flow is indispensable in pinealectomized rats because they may be hypertensive for the first 60 days after pinealectomy (Zanoboni et aI., 1978; Vaughan et aI., 1979) and also because melatonin has been reported to have a regulatory action on cerebral blood flow (Viswanathan et aI., 1990 (Viswanathan et aI., , 1997 Mahle et aI., 1997; Geary et aI., 1997) . We used rats that were pinealectomized 3 months before MCA occlusion to eliminate any possible action of pinealec to my-induced hypertension on stroke outcome (Zano boni et aI., 1978) . Indeed, the mean arterial pressure was not significantly different between experimental groups. More importantly, rCBF changes during MCA occlusion and reperfusion were also not significantly different be tween pinealectomized and sham-operated rats, suggest ing that observed changes in the infarct volume of pine alectomized rats were not related to hemodynamic fac tors. However, we cannot totally exclude the possibility that a lower basal cerebral blood flow level in pinealec tomized rats may have contributed to the increase in infarct volume because the laser-Doppler flowmetry technique we used detects only relative changes in tissue perfusion. However, this is a very unlikely possibility because melatonin has been reported to cause a reduction in basal rCBF in 14-day-old rats (Capsoni et aI., 1995) ; thus, melatonin deficiency is expected, if anything, to cause an increase in basal rCBF.
The pineal gland is the major source of circulating J Cereb Blood Flow Metab, Vol. 19. No. 5, 1999 melatonin, and the extrapineal sources of melatonin do not compensate for melatonin deficiency caused by pine alectomy (Ozaki and Lynch 1976; Lewy et aI., 1980; Bubenik and Brown, 1997) . Our data show that the un favorable action of pinealectomy on cerebral infarct de velopment can be reversed by melatonin administration, supporting the idea that melatonin deficiency may be the factor potentiating the ischemic damage in pinealecto mized rats. However, more convincing evidence can per haps be obtained in future studies by chronic nocturnal administration of melatonin in physiologically relevant doses. Sham-operated rats were also protected by mela tonin, indicating that exogenously given melatonin has a neuroprotective action in cerebral ischemia in animals with a normal diurnal secretion of melatonin as well. Melatonin reduced infarct volume by 40% and signifi cantly improved neurologic deficit in this transient focal ischemia model. In line with these findings, melatonin administration has also been reported to decrease global ischemia-induced damage in the brain (Cho et aI., 1997; Guerrero et aI., 1997) . The antioxidant action of melatonin appears to be the most plausible mechanism among its known effects to account for its neuroprotective action. Neuroprotective effect of antioxidants in cerebral ischemia is well estab lished (Hall, 1997) . Albeit indirectly, maximal protection obtained with administration of melatonin just before the onset of ischemia and reperfusion, the periods when free radical generation is highest, supports this possibility (Kumura et aI., 1996) . Melatonin has been demonstrated to scavenge hydroxyl and peroxyl radicals (Tan et aI., 1993; Pieri et a!., 1994) . As an antioxidant, it has been found to be more powerful than vitamin E, mannitol, and glutathione (Tan et aI., 1993; Pieri et aI., 1994) . Mela tonin has also been shown to decrease oxidative damage to DNA (Tan et aI., 1994) , proteins (Abe et a!., 1994) , and lipids (Melchiorri et aI., 1994 (Melchiorri et aI., , 1995 under various in vivo pathologic conditions. Recently, melatonin admin istration has been reported to attenuate kainic acid induced oxidative damage to DNA in the brain (Uz et aI., 1996) . Interestingly, pinealectomy has been demon strated to increase safrole-induced oxidative DNA dam age in the liver, suggesting that physiologic melatonin release might have an antioxidant activity (Tan et aI., 1994) .
However, loss of a direct antioxidant effect of mela tonin in pinealectomized rats cannot be readily associ ated with the enlarged infarcts because sham-operated rats had also very low plasma melatonin levels when they were subjected to MCA occlusion during the day time. Nocturnal release of melatonin in sham-operated rats 9 to 15 hours after reperfusion is not expected to have a neuroprotective effect because the majority of cells in the ischemic territory become irreversibly injured by that time (Zhang et aI., 1994) . There is increasing evidence suggesting that melatonin secretion may modu late the antioxidant enzyme systems, which may account for the ongoing protective effect of melatonin during the daytime. Pharmacologic levels of melatonin have been reported to stimulate glutathione peroxidase and glucose-6-phosphate dehydrogenase activity in the brain (Bar low-Walden et at., 1995, Pierrefiche and Laborit, 1995) , and nocturnal melatonin release has been shown to co incide with peak neuronal glutathione peroxidase activity (Pablos et aI., 1998) . Melatonin increases brain mRNA levels of glutathione peroxidase and copper-zinc and manganese superoxide dismutases (Antolin et at., 1996; Kotler et at., 1998) . Melatonin also inhibits the activity of some enzymes whose excessive activity may be harm ful under pathologic conditions, such as nitric oxide syn thase (Pozo et at., 1994; Guerrero et aI., 1997) and 5-li poxygenase (Uz et at., 1997) . Pinealectomy has been shown to upregulate 5-lipoxygenase activity in the brain, and release of a tonic inhibitory effect on this enzyme has been proposed as a potential mechanism to explain the increased brain vulnerability in melatonin-deficient rats (Uz et aI., 1997) . If melatonin's protective action is in deed related to its regulatory action on pro-oxidant and antioxidant enzyme systems, melatonin seems to be a unique hormone regulating the organism's self-defense against oxidative damage.
In conclusion, these data strongly suggest that exog enously given melatonin as well as physiologic melato nin release has a neuroprotective action in cerebral isch emia, possibly through an antioxidant mechanism, al though a causal relationship between the enlarged infarcts in pinealectomized rats and melatonin deficiency could not be established unequivocally.
